Optinose to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Rhea-AI Summary

Optinose (NASDAQ:OPTN), a pharmaceutical company specializing in treatments for ear, nose, and throat (ENT) and allergy patients, has announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference. The company's management team will deliver a presentation on September 9, 2024, at 10:00 a.m. ET, providing a comprehensive overview of the company and updates on its business operations.

Investors and interested parties can access a live webcast of the presentation through the Investors page on the Optinose website. For those unable to attend the live event, a replay of the webcast will be available for 30 days following the conference.

News Market Reaction – OPTN

+0.56%

+0.56% Session move

In the trading session that priced this news, OPTN gained 0.56%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

YARDLEY, Pa., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the H.C. Wainwright 26th Annual Global Investment Conference on September 9, 2024 at 10:00 a.m. ET.

To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.

A replay of the webcast will be available for 30 days following the conclusion of the event.

About Optinose
Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on X and LinkedIn.

Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531

FAQ

When is Optinose (OPTN) presenting at the H.C. Wainwright Global Investment Conference?

Optinose (OPTN) is presenting at the H.C. Wainwright 26th Annual Global Investment Conference on September 9, 2024, at 10:00 a.m. ET.

How can I watch Optinose's (OPTN) presentation at the H.C. Wainwright conference?

You can watch a live webcast of Optinose's (OPTN) presentation by visiting the Investors page on the Optinose website.

How long will the replay of Optinose's (OPTN) presentation be available?

The replay of Optinose's (OPTN) presentation will be available for 30 days following the conclusion of the event.

What is Optinose's (OPTN) focus as a pharmaceutical company?

Optinose (OPTN) is a pharmaceutical company focused on developing treatments for patients treated by ear, nose and throat (ENT) and allergy specialists.